Berkeley Capital Partners LLC trimmed its holdings in shares of Procter & Gamble Co (NYSE:PG) by 58.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,552 shares of the company’s stock after selling 3,596 shares during the period. Berkeley Capital Partners LLC’s holdings in Procter & Gamble were worth $232,000 at the end of the most recent reporting period.
Several other hedge funds have also modified their holdings of the company. AE Wealth Management LLC increased its stake in Procter & Gamble by 5.7% in the 3rd quarter. AE Wealth Management LLC now owns 60,185 shares of the company’s stock valued at $5,476,000 after purchasing an additional 3,252 shares in the last quarter. Cutler Investment Counsel LLC increased its stake in Procter & Gamble by 1.7% in the 3rd quarter. Cutler Investment Counsel LLC now owns 86,399 shares of the company’s stock valued at $7,861,000 after purchasing an additional 1,470 shares in the last quarter. Regal Investment Advisors LLC increased its stake in Procter & Gamble by 16.8% in the 3rd quarter. Regal Investment Advisors LLC now owns 52,654 shares of the company’s stock valued at $4,790,000 after purchasing an additional 7,562 shares in the last quarter. Waldron LP increased its stake in Procter & Gamble by 29.2% in the 3rd quarter. Waldron LP now owns 9,722 shares of the company’s stock valued at $884,000 after purchasing an additional 2,200 shares in the last quarter. Finally, Keystone Financial Planning Inc. increased its stake in Procter & Gamble by 25.7% in the 3rd quarter. Keystone Financial Planning Inc. now owns 72,026 shares of the company’s stock valued at $6,553,000 after purchasing an additional 14,734 shares in the last quarter. 59.94% of the stock is owned by institutional investors and hedge funds.
In other news, insider Marc S. Pritchard sold 46,842 shares of the firm’s stock in a transaction on Wednesday, January 24th. The stock was sold at an average price of $89.01, for a total transaction of $4,169,406.42. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Carolyn M. Tastad sold 5,300 shares of the firm’s stock in a transaction on Monday, November 13th. The stock was sold at an average price of $89.18, for a total value of $472,654.00. Following the sale, the insider now owns 57,191 shares in the company, valued at approximately $5,100,293.38. The disclosure for this sale can be found here. Insiders have sold 75,981 shares of company stock worth $6,739,389 in the last 90 days. Insiders own 0.35% of the company’s stock.
Procter & Gamble (NYSE:PG) last announced its earnings results on Tuesday, January 23rd. The company reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.14 by $0.05. The firm had revenue of $17.40 billion for the quarter, compared to analysts’ expectations of $17.39 billion. Procter & Gamble had a return on equity of 20.66% and a net margin of 15.34%. Procter & Gamble’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.08 EPS. equities research analysts forecast that Procter & Gamble Co will post 4.2 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Stockholders of record on Friday, January 19th will be issued a dividend of $0.6896 per share. This represents a $2.76 annualized dividend and a dividend yield of 3.37%. The ex-dividend date is Thursday, January 18th. Procter & Gamble’s dividend payout ratio (DPR) is 73.60%.
PG has been the subject of several research analyst reports. Zacks Investment Research downgraded Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Wednesday, October 18th. Stifel Nicolaus set a $87.00 price objective on Procter & Gamble and gave the company a “hold” rating in a research note on Friday, October 20th. Vetr raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $93.02 price objective for the company in a research note on Monday, October 23rd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Procter & Gamble in a research note on Monday, October 23rd. Finally, Morgan Stanley dropped their price objective on Procter & Gamble from $91.00 to $90.00 and set an “equal weight” rating for the company in a research note on Tuesday, October 24th. One analyst has rated the stock with a sell rating, nine have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $88.38.
COPYRIGHT VIOLATION WARNING: “Berkeley Capital Partners LLC Has $232,000 Stake in Procter & Gamble Co (PG)” was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://sportsperspectives.com/2018/02/08/berkeley-capital-partners-llc-has-232000-stake-in-procter-gamble-co-pg.html.
About Procter & Gamble
The Procter & Gamble Company is focused on providing branded consumer packaged goods to the consumers across the world. The Company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care, and Baby, Feminine & Family Care. The Company sells its products in approximately 180 countries and territories primarily through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores and pharmacies.
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.